MarketInOut Stock Screener Log In | Sign Up
 

Fractyl Health Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/16/2026 16:00
Fractyl Health Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization24.54 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

60.40
Transformational upside

Relative Strength

0 / 100
Severely lagging

ROE

-6,790
Deeply negative

ROA

-110
Deeply negative

Business Description

Fractyl Health is a medical company focused on finding lasting solutions for type 2 diabetes and obesity. Its two main programs include a minimally invasive outpatient procedure that targets a root cause of these conditions in the digestive tract, and a gene therapy designed to produce long-term remission by changing how the pancreas regulates key metabolic hormones. Founded in 2010 and based in Burlington, Massachusetts, the company has grown from its origins as Fractyl Laboratories into a broader health-focused organization.

Key Fundamentals

EPS-10.56
ROE-6,790
ROIC-197
ROA-110
EBITDA, mln-105
EV / EBITDA-0.99
EV / EBIT-0.98

Quote Details

Last 1.55
Change -2.61 (-62.74%)
Open 2.14
Volume 14,782,522
Turnover 22,912,908
Average Volume 889,724

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price60.40
Short Ratio1.19
Short % of Float1.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -64.93% 0 / 100   
1 Month -78.14% 1 / 100   
2 Months -83.04% 1 / 100   
6 Months -77.31% 5 / 100   
1 Year -90.29% 5 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us